nicotinamide mononucleotide has been researched along with angiotensin ii in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cha, DR; Han, JY; Han, KH; Han, SY; Kang, YS; Kim, BK; Kim, HK; Ko, GJ; Lee, MH; Park, YG; Song, HK | 1 |
| Abudupataer, M; Lai, H; Li, J; Ming, Y; Wang, C; Xiang, B; Yin, X; Zhu, K | 1 |
2 other study(ies) available for nicotinamide mononucleotide and angiotensin ii
| Article | Year |
|---|---|
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy.
Topics: Acrylamides; Adipocytes, White; Angiotensin II; Animals; Blotting, Western; Cell Survival; Cells, Cultured; Collagen Type I; Cytokines; Diabetic Nephropathies; Gene Expression; Glucose; Glucose Transporter Type 1; Mesangial Cells; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Phosphorylation; Piperidines; Plasminogen Activator Inhibitor 1; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Insulin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Transforming Growth Factor beta1 | 2008 |
Nicotinamide Mononucleotide Alleviates Angiotensin II-Induced Human Aortic Smooth Muscle Cell Senescence in a Microphysiological Model.
Topics: Angiotensin II; Animals; Aortic Aneurysm; Humans; Myocytes, Smooth Muscle; NAD; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase | 2023 |